Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Open Label Extension to Assess the Safety of Long-Term Treatment With Ampion for Severe Osteoarthritis (OA) of the Knee

ClinicalTrials.gov ID: NCT03349645

Public ClinicalTrials.gov record NCT03349645. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 10:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open Label Extension Study to Assess the Safety of Long-Term Treatment With a 4 mL Intra-Articular Injection of Ampion in Adults With Pain Due to Severe Osteoarthritis of the Knee

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Open Label Extension (OLE) study will assess the safety of long-term treatment with a 4 mL intra-articular injection of Ampion™ in adults with pain due to severe osteoarthritis of the knee

Study identification

NCT ID
NCT03349645
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ampio Pharmaceuticals. Inc.
Industry
Enrollment
94 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
40 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 8, 2017 (Actual)
Primary completion
Oct 4, 2018 (Actual)
Completion
Oct 4, 2018 (Actual)
Last update posted
Oct 3, 2022

2017 – 2018

United States locations

U.S. sites
11
U.S. states
9
U.S. cities
11
Facility City State ZIP Site status
Central Research Associates, Inc. Birmingham Alabama 35205 —
CORE Orthopaedic Medical Center Encinitas California 92024 —
St. Joseph Heritage Fullerton California 92835 —
Westlake Medical Research Thousand Oaks California 91360 —
Drug Studies America Marietta Georgia 30060 —
Healthcare Research Netword Blue Island Illinois 60406 —
Heartland Research Associates Wichita Kansas 67207 —
Healthcare Network Research Hazelwood Missouri 63042 —
Coastal Carolina Center at Lowcountry Orthopaedics North Charleston South Carolina 29406 —
Tekton Research Austin Texas 78745 —
Northwest Clinical Research Center Bellevue Washington 98007 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03349645, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 3, 2022 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03349645 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →